Our relationships with stakeholders are fundamental to improving our corporate responsibility efforts. Engagement with Pfizer's stakeholders helps us understand the larger context and impacts of our operations, learn about expectations for our performance, and assess emerging issues that may affect our business. We operate with a stakeholder model that recognizes the inherent interconnectedness of the goals of Pfizer and its stakeholders. This model informs an approach to engagement that moves beyond transactions between Pfizer and individual stakeholders to a network of connected organizations that all have important roles in addressing social and environmental issues. This approach has helped us identify mutual perspectives and goals with stakeholders and to take a more collaborative approach to these relationships. Our overarching goal is the sameýýýimproved global health and prosperity. We have received essential input from stakeholders over the last two years. For example, in April 2008, stakeholders from more than a dozen public and private organizations met with Pfizer Global Operations leaders from around the world to help us develop our new Global Access to Medicines strategy. These stakeholders helped us define the opportunities and expectations associated with work in this area. Many of these stakeholders have become engaged partners in building this new approach to access. Throughout the report, we have highlighted stakeholder feedback. Please look for these to learn more about how we engage with stakeholders and how they view our performance.
